BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mustafa AS. BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers. Vaccines (Basel) 2020;8:E736. [PMID: 33291702 DOI: 10.3390/vaccines8040736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Panaiotov S, Hodzhev Y, Tolchkov V, Tsafarova B, Mihailov A, Stefanova T. Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia. Vaccines (Basel) 2021;9:237. [PMID: 33803448 DOI: 10.3390/vaccines9030237] [Reference Citation Analysis]
2 Mustafa AS. Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis. Vaccines (Basel) 2021;9:972. [PMID: 34579209 DOI: 10.3390/vaccines9090972] [Reference Citation Analysis]
3 Liu L, Shi W, Xiao X, Wu X, Hu H, Yuan S, Liu K, Liu Z. BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP‑1 cells via the Rb/E2F1 pathway in cervical carcinoma. Oncol Rep 2021;46:245. [PMID: 34581419 DOI: 10.3892/or.2021.8196] [Reference Citation Analysis]
4 Le I, Dhandayuthapani S, Chacon J, Eiring AM, Gadad SS. Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics. Vaccines 2022;10:816. [DOI: 10.3390/vaccines10050816] [Reference Citation Analysis]
5 Feng F, Wen Z, Chen J, Yuan Y, Wang C, Sun C. Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases. Viruses 2022;14:520. [DOI: 10.3390/v14030520] [Reference Citation Analysis]
6 Mustafa AS. Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins. Vaccines (Basel) 2021;9:27. [PMID: 33430286 DOI: 10.3390/vaccines9010027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kim BJ, Jeong H, Seo H, Lee MH, Shin HM, Kim BJ. Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections. Front Immunol 2021;12:712274. [PMID: 34512635 DOI: 10.3389/fimmu.2021.712274] [Reference Citation Analysis]